Julian Lob-Levyt UPDATE ON GAVI Global Immunisation Meeting New York, February 2009
The GAVI Alliance Board structure
GAVI Alliance
�Informal, not a legal entity
�Partner representatives
�Public sector expertise(plus vaccine industry)
�Programmatic oversight andpolicy development
�Responsible for approvingcountry programmes
Global Immunisation Meeting
New York, February 2009
GAVI Fund
� A legal entity
� Individual volunteers
� Private sector expertise
�Financial oversight(investment, accounting,auditing)
�Responsible for approvingfinancing for countryprogrammes
1
Positive outcomes for implementing countries
� Countries are better represented on both the Board and its committees.
� The Programme & Policy Committee will bring country perspectives to the forefront of all policy decisions.
� The partnership does not change.
Global Immunisation Meeting
New York, February 2009
2
Immunisation coverage with DTP3,hepatitis B and Hib vaccines inGAVI-supported countries, 2000-2009
Global Immunisation Meeting
New York, February 2009
Source/credits: WHO-UNICEF coverage estimates for 1980-2007, as of August 2008; WHO-ICE T coverage projections for 2008-2010, as of September 2008
4
Global Immunisation Meeting
New York, February 2009
6
Close to US$ 4 billion approved for country programmes through 2015
Towards MDG 4 Projected expenditure, 2009-2015
Estimates as at January 2009* HPV, JE vaccines, rubella and typhoid** Hib, hepB (tetra/monovalent), yellow fever, measles second dose Microsoft Office
Excel Binary Worksheet
Country co-financing
� Boosting sustainability and country ownership of immunisation programmes.
� Compulsory for some countries from 2008.
� Well received: most countries fulfilled commitments. Some paid more – and a few struggle.
� Country response to the policy show that vaccines are priority.
Rasoka Thor/UNICEF Cambodia
Transparency & Accountability Policy rationale
� Increase in GAVI cash support: projected to be over $200m in 2009.
� Need to increase financial assurances of country programme implementation.
9
Global Immunisation Meeting
New York, February 2009
Christine Nesbit/GAVI Alliance
Transparency & Accountability Policy implementation
Began on 1 January 2009 and includes:
� Strengthen financial management sectionsin all new proposals and annual progress reports;
� Involve financial management experts on the Independent Review Committee;
� Develop an early warning system – a modelling tool that allows GAVI to identify risks pre-emptively;
� Conduct financial management assessment (FMA).
10
Global Immunisation Meeting
New York, February 2009
Strengthening and aligning reviews
11
Global Immunisation Meeting
New York, February 2009
APR (Annual progress report) 15 May 2009 submission deadline
15 May 1 September
Measuring impact
�Strong need for valid, reliable and useful measures of delivery and performance of GAVI support.
�GAVI partner concern: current data insufficient.
�KEY ACTIONS taken to address measurement challenge.
Global Immunisation Meeting
New York, February 2009
12
Accelerated Vaccines Introduction: The Plan
� Assist countries make decisions on introduction of pneumo & rota vaccines.
� Develop platform for introduction of other new vaccines.
� Target of 42 pneumo and 44 rota introductions by 2015.
� Detailed work-plan for 2009, with partners & AVI -TAC* roles mapped.
* TAC = Technical Advisory Consortium (merged ADIPs & Hib initiative)
Global Immunisation Meeting
New York, February 2009
Other key issues
� Vaccine Investment Strategy currently developed:Board agreed focus on HPV, Rubella, JapaneseEncephalitis and Typhoid (subject to finance).
� Future of service / systems components from 2010 (HSS and CSO evaluations and ISS future)
� Technical support: quality, availability, sustainability and transparency
� Eligibility criteria
14
Global Immunisation Meeting
New York, February 2009
Way forward
� Keep GAVI Alliance being accountable and transparent.
� International Health Partnership (IHP+) – a milestone in thehistory of global health programming and financing.
� GAVI Alliance partners: foster the continued collaboration for in country activities.
� Regional Working Groups: strengthen the compositionHSS & Immunisation) and the function to better support implementation of GAVI policies.
� Strengthening civil society organisation involvement and representation.
� Manage the impact of the international financial crisis.
15
Global Immunisation Meeting
New York, February 2009